SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-15-261176
Filing Date
2015-07-23
Accepted
2015-07-23 16:18:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d14378dsc13d.htm SC 13D 122839
2 DIRECTOR INDEMNIFICATION AGREEMENT d14378dex995.htm EX-99.5 65843
3 JOINT FILING AGREEMENT d14378dex996.htm EX-99.6 3999
4 POWERS OF ATTORNEY d14378dex997.htm EX-99.7 5177
  Complete submission text file 0001193125-15-261176.txt   199255
Mailing Address 708 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 301-869-9683
OPGEN INC (Subject) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88842 | Film No.: 151002507
SIC: 8071 Services-Medical Laboratories

Mailing Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889
Business Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 908-740-4000
Merck Global Health Innovation Fund, LLC (Filed by) CIK: 0001547132 (see all company filings)

IRS No.: 000000000
Type: SC 13D